Müller D, Sommer M, Kretzschmar M, Zimmermann T, Buko V U, Lukivskaya O, Dargel R
Institute of Pathological Biochemistry, Friedrich Schiller University, Jena, Soviet Union.
Arch Toxicol. 1991;65(3):199-203. doi: 10.1007/BF02307309.
Microsomes and isolated hepatocytes from thioacetamide (TAA)-induced macronodularly cirrhotic rat livers were analysed for their susceptibility to unstimulated and stimulated lipid peroxidation measured as malondialdehyde (MDA) formation. In microsomes from TAA-induced macronodularly cirrhotic livers the MDA production stimulated either by ascorbate-iron or by ADP-iron in a NADPH-regenerating system was decreased. Hepatic microsomes from TAA-treated rats exhibited a reduced cytochrome P450 content and lowered activities of ethylmorphine N-demethylase, ethoxycoumarin O-deethylase and epoxide hydrolase. Besides this, the microsomal fatty acid pattern of phosphatidylcholine and phosphatidylethanolamine was significantly changed after 6 months of TAA administration. The 18:2/20:4 ratio of phospholipid fatty acids was markedly increased. In contrast to the microsomes, in isolated hepatocytes from macronodularly cirrhotic livers the iron- and ascorbate-iron-stimulated MDA formation was increased. The hepatocellular GSH content was unaffected by TAA pretreatment, whereas the GSSG content exhibited a significant increase, thus leading to a pronounced reduction of the GSH/GSSG ratio. The calcium channel blocker verapamil (200 microM), known to be able to scavenge OH' radicals produced by the Fenton reaction, revealed an inhibitory effect on ascorbate-iron- and ADP-iron-stimulated lipid peroxidation in hepatocytes from normal as well as TAA-treated livers which is attributed to its antioxidative properties. In summary, lipid peroxidation is altered in TAA-induced macronodularly cirrhotic rat livers. Furthermore, the data clearly show that isolated microsomes and parenchymal cells prepared from cirrhotic livers react differently to prooxidant stimuli.
对硫代乙酰胺(TAA)诱导的大结节性肝硬化大鼠肝脏中的微粒体和分离的肝细胞进行分析,检测其对未刺激和刺激状态下脂质过氧化的敏感性,脂质过氧化以丙二醛(MDA)的生成量来衡量。在TAA诱导的大结节性肝硬化肝脏的微粒体中,在NADPH再生系统中,抗坏血酸 - 铁或ADP - 铁刺激产生的MDA产量降低。TAA处理大鼠的肝微粒体细胞色素P450含量降低,N - 脱甲基酶、O - 脱乙基酶和环氧水解酶的活性也降低。除此之外,TAA给药6个月后,微粒体中磷脂酰胆碱和磷脂酰乙醇胺的脂肪酸模式发生了显著变化。磷脂脂肪酸的18:2/20:4比例明显增加。与微粒体不同的是,在大结节性肝硬化肝脏分离的肝细胞中,铁和抗坏血酸 - 铁刺激的MDA生成增加。肝细胞内谷胱甘肽(GSH)含量不受TAA预处理的影响,而氧化型谷胱甘肽(GSSG)含量显著增加,从而导致GSH/GSSG比值明显降低。钙通道阻滞剂维拉帕米(200 microM)已知能够清除芬顿反应产生的OH'自由基,它对正常肝脏以及TAA处理肝脏的肝细胞中抗坏血酸 - 铁和ADP - 铁刺激的脂质过氧化具有抑制作用,这归因于其抗氧化特性。总之,TAA诱导的大结节性肝硬化大鼠肝脏中的脂质过氧化发生了改变。此外,数据清楚地表明,从肝硬化肝脏制备的分离微粒体和实质细胞对促氧化剂刺激的反应不同。